AXIM BIOTECHNOLOGIES, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $688.43K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-19 | |
| 2023-03-31 | $688.43K 10-Q/A · filed 2024-05-22 |